In addition, inhibition of extracellular HSP70 (one of the TLR4 ligands) binding to TLR4 was found to attenuate pressure overload-induced cardiac hypertrophy and fibrosis by modulating ERK and p38 MAPK activity (46), further corroborating the previous studies. Here, TLR4 is linked to cardiac hypertrophy.